As of 2025-10-21, the Relative Valuation of Maravai LifeSciences Holdings Inc (MRVI) is (19.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.52 USD, the upside of Maravai LifeSciences Holdings Inc based on Relative Valuation is -658.9%.
The range of the Relative Valuation is (15.74) - (28.55) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 20.6x - 37.4x | 25.8x |
| Fair Price | (15.74) - (28.55) | (19.67) |
| Upside | -547.1% - -911.1% | -658.9% |
| Date | P/E |